– Patient dosing initiated in LUMUS, a 388 patient Phase 2b clinical trial of ESK-001 for the treatment of SLE – – Patient dosing initiated in OPTYK-1, a proof-of-concept clinical trial of ESK-001 for ...
The middle layer of the eye, known as the uvea, becomes inflamed when someone has eye inflammation or uveitis.